With the support of BGM Associates, ASAN Medical Center (AMC) – one of the leading hospitals in Seoul, South Korea – has entered into a Research and Development Collaboration Agreement with Piramal Imaging S.A.. The parties plan to conduct clinical studies at AMC with the intent of gaining regulatory approval for commercialization of innovative molecular tracers for Positron Emission Tomography (PET) in South Korea.
The collaboration comprises novel molecular tracers for oncology, neurology and cardiovascular applications, including, for instance, imaging agents for the detection and quantification of tau tangles in the brain and thrombi in the vascular system.
Both parties intend to jointly assign a future commercial partner for the production, supply and the marketing of the 18F-based tracers in South Korea.
Official press release
The collaboration comprises novel molecular tracers for oncology, neurology and cardiovascular applications, including, for instance, imaging agents for the detection and quantification of tau tangles in the brain and thrombi in the vascular system.
Both parties intend to jointly assign a future commercial partner for the production, supply and the marketing of the 18F-based tracers in South Korea.
Official press release
